Implantable cardioverter defibrillator therapy in paediatric practice: A single-centre UK experience with focus on subcutaneous defibrillation

Europace

Volumn 15, Issue 4, 2013, Pages 523-530

  Griksaitis, Michael J ^a   Rosengarten, James A ^a   Gnanapragasam, James P ^a   Haw, Marcus P ^a   Morgan, John M ^a  

^a UNIVERSITY HOSPITAL SOUTHAMPTON NHS FOUNDATION TRUST   (United Kingdom)

Author keywords

Electrophysiology; Heart arrest; Implantable cardioverter defibrillators; Paediatrics; Sudden death

Indexed keywords

AMIODARONE; ANTIARRHYTHMIC AGENT; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; FLECAINIDE;

ADOLESCENT; AGE; ARTICLE; BODY WEIGHT; BRUGADA SYNDROME; CARDIOVASCULAR MORTALITY; CATECHOLAMINERGIC POLYMORPHIC VENTRICULAR TACHYCARDIA; CHILD; CLINICAL ARTICLE; CONGENITAL HEART DISEASE; DEFIBRILLATION; FEMALE; FOLLOW UP; HEART ARREST; HEART REPOLARIZATION; HEART VENTRICLE ARRHYTHMIA; HEART VENTRICLE FIBRILLATION; HUMAN; HYPERTROPHIC CARDIOMYOPATHY; IMPLANTABLE CARDIOVERTER DEFIBRILLATOR; LONG QT SYNDROME; MALE; OUT OF HOSPITAL CARDIAC ARREST; PATIENT SAFETY; PEDIATRICS; PRIORITY JOURNAL; RESUSCITATION; RETROSPECTIVE STUDY; SCHOOL CHILD; SINUS TACHYCARDIA; SUDDEN DEATH; SUPRAVENTRICULAR TACHYCARDIA; UNITED KINGDOM;

ADOLESCENT; AGE FACTORS; ANTI-ARRHYTHMIA AGENTS; ARRHYTHMIAS, CARDIAC; CHILD; CHILD, PRESCHOOL; DEATH, SUDDEN, CARDIAC; DEFIBRILLATORS, IMPLANTABLE; ELECTRIC COUNTERSHOCK; ENGLAND; FEMALE; HUMANS; INFANT; MALE; PROSTHESIS DESIGN; PROSTHESIS FAILURE; RETROSPECTIVE STUDIES; RISK FACTORS; TIME FACTORS; TREATMENT OUTCOME;

EID: 84875995136     PISSN: 10995129     EISSN: 15322092     Source Type: Journal    
DOI: 10.1093/europace/eus388     Document Type: Article

References (27)

1. Wren C. Sudden death in children and adolescents. Heart 2002;88:426-31.
2. Jons C, Moss AJ, Goldenberg I, Liu J, McNitt S, Zareba W et al. Risk of fatal arrhythmic events in long QT syndrome patients after syncope. J Am Coll Cardiol 2010;55:783-8.
3. Denjoy I, Lupoglazoff JM, Guicheney P, Leenhardt A. Arrhythmic sudden death in children. Arch Cardiovasc Dis 2008;101:121-5.
4. Stephenson EA, Berul CI. Electrophysiological interventions for inherited arrhythmia syndromes. Circulation 2007;116:1062-80.
5. Lewandowski M, Sterlinski M, Maciag A, Syska P, Kowalik I, Szwed H et al. Longterm follow up of children and young adults treated with implantable cardioverter-defibrillator: the authors' own experience with optimal implantable cardioverter-defibrillator programming. Europace 2010;12:1245-50.
6. Bardy GH, Smith WM, Hood MA, Crozier IG, Melton IC, Jordaens L et al. An entirely subcutaneous implantable cardioverter defibrillator. N Engl J Med 2010;363: 36-44.
7. McLeod K, Connelly D, McLean A. Abstract 12993: subcutaneous implantable cardioverter defibrillator in paediatric patients: early experience. Circulation 2010;122:A12993.
8. Gold MR, Theuns DA, Knight BP, Sturdivant JL, Sanghera R, Ellenbogen KA et al. Head-to-head comparison of subcutaneous and transvenous ICD arrhythmia detection algorithms: the START study. J Cardiovasc Electrophysiol 2012;4:359-66.
9. Alexander ME, Cecchin F, Walsh EP, Triedman JK, Bevilacqua LM, Berul CI. Implications of implantable cardioverter defibrillator therapy in congenital heart disease and pediatrics. J Cardiovasc Electrophysiol 2004;15:72-6.
10. McLeod KA. Cardiac pacing in infants and children. Heart 2010;96:1502-8.
11. Celiker A, Olgun H, Karagoz T, Ozer S, Ozkutlu S, Alehan D. Midterm experience with implantable cardioverter-defibrillators in children and young adults. Europace 2010;12:1732-8.
12. National Institute for Health and Clinical Excellence. Implantable Cardioverter Defibrillators for Arrhythmias. Technology Appraisal 95, 2006.
13. Crespo EM, Kim J, Selzman KA. The use of implantable cardioverter defibrillators for the prevention of sudden cardiac death: a review of the evidence and implications. Am J Med Sci 2005;329:238-46.
14. Berul CI, Van Hare G, Kertesz NJ, Dubin AM, Cecchin F, Collins KK et al. Results of a multicentre retrospective implantable cardioverter defibrillator registry of pediatric and congenital heart disease patients. J Am Coll Cardiol 2008;51:1685-91.
15. Hamilton RM, Dorian P, Gow RM, Williams WG. Five-year experience with implantable defibrillators in children. Am J Cardiol 1996;77:524-6.
16. Hsia TY, Bradley SM, LaPage MJ, Whelan S, Saul JP, Ringewald JM et al. Novel minimally invasive, intrapericardial implantable cardioverter defibrillator coil system: a useful approach to arrhythmia therapy in children. Ann Thorac Surg 2009;87: 1234-9.
17. Karpawich PP. Technical aspects of pacing in adult and paediatric congenital heart disease. Pacing Clin Electrophysiol 2008;31:S28-31.
18. Sterlinski M, Przybylski A, Gepner K, Syska P, Maciaq A, Lewandowski M et al. Over 10 years with an implantable cardioverter-defibrillator - a long term followup of 60 patients. Kardiol Pol 2010;68:1023-9.
19. Dorwarth U, Frey B, Dugas M, Matis T, Fiek M, Schmoeckel M et al. Transvenous defibrillation leads: high incidence of failure during long-term follow-up. J Cardiovasc Electrophysiol 2003;14:38-43.
20. Kleemann T, Becker T, Doenges K, Vater M, Senges J, Schneider S et al. Annual rate of transvenous defibrillation lead defects in implantable cardioverterdefibrillators over a period of .10 years. Circulation 2007;115:2474-80.
21. Hauser RG, Hayes DL. Increasing hazard of Sprint Fidelis implantablecardioverter- defibrillator lead failure. Heart Rhythm 2009;6:605-10.
22. Haggani HM, Mond HG. The implantable cardioverter-defibrillator lead: principles, progress, and promises. Pacing Clin Electrophysiol 2009;32:1336-53.
23. Rickard J, Wilkoff BL. Extraction of implantable cardiac electronic devises. Curr Cardiol Rep 2011;13:407-14.
24. Jarman JW, Lascelles K, Wong T, Markides V, Clague JR, Till J. Clinical experience of entirely subcutaneous implantable cardioverter-defibrillators in children and adults: cause for caution. Eur Heart J 2012;33:1351-9.
25. Kaltman JR, Gaynor JW, Rhodes LA, Buck K, Shah MJ, Vetter VL et al. Subcutaneous array with active can implantable cardioverter defibrillator configuration: a follow-up study. Congenit Heart Dis 2007;2:125-9.
26. Sears SF, Hazelton AG, St Amant J, Matchett M, Kovacs A, Vazquez LD et al. Quality of life in pediatric patients with implantable cardioverter defibrillators. Am J Cardiol 2011;107:1023-7.
27. Koopman HM, Vrijmoet-Wiersma CM, Langius JN, van den Heuvel F, Clur SA, Blank CA et al. Psychological functioning and disease-related quality of life in pediatric patients with an implantable cardioverter defibrillator. Pediatr Cardiol 2012; 33:569-75.